Chaperones are the primary regulators of the proteostasis network and are known to facilitate protein folding, inhibit protein aggregation, and promote disaggregation and clearance of misfolded aggregates inside cells. We have tested the effects of five chaperones on the toxicity of misfolded oligomers preformed from three different proteins added extracellularly to cultured cells. All the chaperones were found to decrease oligomer toxicity significantly, even at very low chaperone/protein molar ratios, provided that they were added extracellularly rather than being overexpressed in the cytosol. Infrared spectroscopy and site-directed labeling experiments using pyrene ruled out structural reorganizations within the discrete oligomers. Rather, confocal microscopy, SDS-PAGE, and intrinsic fluorescence measurements indicated tight binding between oligomers and chaperones. Moreover, atomic force microscopy imaging indicated that larger assemblies of oligomers are formed in the presence of the chaperones. This suggests that the chaperones bind to the oligomers and promote their assembly into larger species, with consequent shielding of the reactive surfaces and a decrease in their diffusional mobility. Overall, the data indicate a generic ability of chaperones to neutralize extracellular misfolded oligomers efficiently and reveal that further assembly of protein oligomers into larger species can be an effective strategy to neutralize such extracellular species. Please refer to the published version for citation purposes.
Introduction \body
The ability of living systems to maintain their peptides and proteins in soluble and functional states is the result of evolutionary selection of the physicochemical and conformational characteristics of these macromolecules (1) and owing to an array of biological mechanisms that together act to ensure proteostasis (2) . Failures of the protective and regulatory mechanisms can result in a wide variety of pathological conditions, including those associated with the accumulation of protein aggregates, both in the cytosol and in the extracellular space (3, 4) . Molecular chaperones are proteins that play a central role in the avoidance of protein misfolding and aggregation (5) (6) (7) (8) .
Most known chaperones are intracellular (7, 8) , but some of them are secreted and are collectively referred to as extracellular chaperones (9) . Chaperones are known to have a range of different functions, such as assisting in protein folding (7) , inhibiting protein aggregation (10) , causing the disaggregation of aberrant protein oligomers (6) , and facilitating the degradation of misfolded proteins (11) .
In this study we have examined the effects of two intracellular and three extracellular chaperones on the toxicity of extracellularly added oligomers formed by three different peptides/proteins, namely the 42-residue amyloid β peptide (Aβ 42 ), the islet amyloid polypeptide (IAPP) and the N-terminal domain of the HypF protein from E. coli (HypF-N). We focused our attention on small oligomers as such species are generally highly toxic to cultured cells and are thought to be the major deleterious species in a range of protein aggregation diseases (4) . We show that the chaperones markedly decrease the toxicity of preformed oligomers, with significant effects being observed even at molar ratios of protein:chaperone as high as 500:1. We show in addition that chaperones bind to the oligomers and promote their clustering into larger aggregates, in the absence of any disaggregation or major structural reorganisation. Overall, these results provide suggestions on novel mechanisms by which molecular chaperones are cytoprotective extracellularly and also reveal new determinants of protein oligomer toxicity and strategies to convert protein aggregates that are toxic to cultured cells into innocuous species.
RESULTS

Chaperones reduce oligomer toxicity.
We generated toxic oligomers from Aβ 42 , IAPP and HypF-N, as described previously (12) (13) (14) . After 1 h incubation in the cell culture medium, they were added to human SH-SY5Y neuroblastoma cultured cells, at a corresponding monomer concentration of 12 µM. Under these conditions, all oligomers were found to decrease the MTT reduction of the cells by 30-40%, demonstrating their toxic nature (Fig. 1A) . The oligomers were then subjected to the same procedure but incubated for 1 h in the cell culture medium containing either αB-crystallin (αBcr), Hsp70, clusterin (Clu), haptoglobin (Hp) or α 2 -macroglobulin (α 2 M) before their addition to SH-SY5Y cells. For these five chaperones and for all our experiments, the protein:chaperone molar ratios were 5:1, 5:1, 10:1, 15.1 and 100:1, respectively, unless otherwise stated. In each case the cells were found to reduce MTT to levels similar to untreated cells and to cells treated with the native proteins ( Fig 1A) . Hsp70 was found to be equally effective with or without ATP (SI Appendix. Fig. S1 ).
When the oligomers were incubated in the cell culture medium with proteins that do not act as chaperones, either hen lysozyme (HEWL) or bovine serum albumin (BSA), they maintained their toxicity (Fig. 1A) . Moreover, chaperones were not found to be protective against other forms of stress, such as H 2 O 2 -mediated oxidation (SI Appendix. Fig. S2 ). These results therefore indicate that all five chaperones markedly decrease the toxicity of oligomers formed by three different proteins, with these effects being specific to the chaperones (relative to other proteins) and to protein oligomer toxicity (relative to other forms of stress).
The experiments with HypF-N oligomers and chaperones were repeated by varying the concentrations of each of the five chaperones (from 2.4 µM to 6 nm), while maintaining constant that of HypF-N (12 µM). All chaperones had significant effects even at HypF-N:chaperone molar ratios of 500:1, becoming ineffective only at molar ratios of 2000:1 (Fig. 1B) . Thus, chaperones appear to markedly decrease oligomer toxicity at greatly sub-stoichiometric concentrations. The experiments were repeated with HypF-N, Aβ 42 and IAPP oligomers (12 µM) using varying concentrations of antibodies sequence-specific to the proteins (from 2.4 µM to 6 nm). Compared to the chaperones, higher concentrations of antibodies were required to reduce the toxicity of the respective oligomers (SI Appendix. Fig. S3 ).
Chaperones prevent the interaction of oligomers with cellular membranes.
For the following experiments we chose to focus on the oligomers from a single protein, HypF-N.
Indeed, under different experimental conditions, HypF-N can aggregate into toxic (type A, the same used in the present work) or nontoxic (type B) oligomers; the two species are morphologically similar as determined by atomic force microscopy (AFM) and bind Thioflavin T (ThT) to similar levels, making it possible to carry out valuable control experiments (14) . In addition, differences in the structure of toxic and nontoxic oligomers have been detected using the fluorescent probe N-(1-pyrene)maleimide (PM) (14) , providing a valuable method to probe structural changes experienced by the oligomers following their exposure to chaperones (see below).
HypF-N oligomers have been shown to be toxic via aberrant interactions with the cell membrane, causing a rapid influx of Ca 2+ ions from the cell culture medium to the cytosol (15).
This triggers a slower and complex cellular cascade manifested by increases in intracellular ROS and in caspase-3 activity, and as a release of intracellular calcein from cells, eventually leading to apoptosis (15) . Pre-incubation of HypF-N oligomers (12 µM monomer) with each of the five chaperones in the cell culture medium for 1 h, prior to addition to the cells, was found to inhibit the increase of intracellular Ca 2+ levels caused by the oligomers (Fig. 2) , with the degree of inhibition increasing with pre-incubation time (SI Appendix. Fig. S4 ). All other events were also reduced markedly, with the extent of reduction again being dependent on the time of pre-incubation (SI Appendix. Fig. S5-7 ). We conclude, therefore, that all five chaperones examined here can inhibit the initial biochemical events induced by toxic HypF-N oligomers, namely the influx of Ca Pre-incubation of the oligomers with each chaperone led to little or no HypF-N entry (SI Appendix.
Fig. S8-9)
. The oligomers were predominantly detected outside or attached to the cells, but not within them, as confirmed by analysing the confocal images at median planes. These observations therefore show that the chaperones inhibit oligomer internalisation, at least under the conditions used here, rather than stimulating their intracellular degradation following endocytosis.
We next took advantage of human embryonic kidney 293 (HEK293) cell lines overexpressing either human Hsp70 (HSPA1A) or Hsp22 (HSPB8) in the cytosol (16, 17) ; the latter is a small heat shock protein containing an α-crystallin domain. Both cell lines were found to be resistant to intracellular protein aggregation-associated cell death (SI Appendix. Overall, therefore, the deleterious effects of HypF-N oligomers can be abolished by chaperones provided that the chaperone-oligomer interactions occur before the oligomers are able to interact with the cell membranes and initiate the Ca 2+ influx. In agreement with this conclusion, chaperones overexpressed intracellularly are not protective against extracellular oligomers.
Chaperones bind to and assemble the oligomers into larger species.
Three possible non-exclusive molecular mechanisms can be hypothesised to explain how chaperones reduce oligomer toxicity: (i) the chaperones disassemble the oligomers; (ii) they bind to oligomers and promote their assembly into larger and innocuous aggregates, (iii) they catalyse a structural reorganisation into nontoxic forms. The ability of HypF-N oligomers to bind ThT was maintained following pre-incubation with each of the chaperones, whereas neither native HypF-N nor free chaperones had such an ability (SI Appendix. Fig. S11 ). A process of chaperone-mediated oligomer disassembly can thus be excluded.
To investigate whether chaperones bind to the oligomers and promote their further assembly, we first used AFM. Discrete oligomers with a height of 2-6 nm were observed by AFM in the absence of chaperones (Fig. 3A) , but significantly larger aggregates are evident with αBcr (Fig. 3B) or α 2 M (Fig. 3C ), used here as representative chaperones. On higher magnification of these images, the aggregates appear as clusters of oligomers (Fig. 3D) . In some cases more complex structures are observed, consisting of very large aggregates of irregular shape with typical heights of a few tens of nm, often surrounded by clusters of more distinct oligomers. Large assemblies are not observed in samples containing only chaperones (Fig. 3E,F) .
The AFM data show that chaperones promote the assembly of the oligomers into larger species, but do not provide information on whether or not the chaperones remain bound to them. The oligomers can also be observed with confocal microscopy as, unlike free chaperones, they readily adhere to the glass coverslips (Fig. 3G ). Images obtained using oligomers pre-incubated with αBcr or α 2 M show larger aggregates and co-localisation of the chaperones with the large oligomer clusters (Fig. 3H,I ). Although this technique has a resolution that enables only visualisation of clusters of oligomers or areas enriched with oligomers (not individual oligomers), it shows that the chaperones are bound to the large clusters of oligomers.
In another experiment, samples of HypF-N oligomers incubated with each chaperone were centrifuged to separate the soluble (supernatant, SN) and insoluble (pellet, P) fractions, which were then analysed by SDS-PAGE. In the control samples containing oligomers or αBcr alone, the HypF-N monomer (MW ~10.5 kDa) and the αBcr monomer (MW ~20 kDa) bands were found only in the P and SN fractions, respectively (Fig. 4A ). In the sample containing both species, the HypF-N band was found only in the P fraction, whereas αBcr was found to partition between the P and SN fractions (Fig. 4A ). This finding indicates that a fraction of αBcr is bound to the oligomers.
Moreover, the αBcr found in the P fraction remains tightly associated with the oligomers after resuspension of the pellet and further incubation (SI Appendix. Fig. S15 ). Similar results were obtained using α 2 M (Fig. 4B ), Hsp70 (SI Appendix. Fig. S12A ), Clu (SI Appendix. Fig. S13A ) and Hp (SI Appendix. Fig. S14A ). The results, therefore, confirm that binding occurs between the oligomers and all five chaperones studied here. Intrinsic fluorescence spectra of the SN fractions collected in each experiment were also acquired (Fig. 4C, 4D and SI Appendix. Fig. S12B , S13B, S14B). The SNs obtained from the samples where both oligomers and chaperones were present yielded fluorescence spectra that were less intense than the corresponding samples in which only the chaperone was present, confirming that a fraction of the chaperone population had been separated through centrifugation.
Overall, the AFM data indicate that chaperones promote the assembly of the oligomers into larger species, whereas the other methods of analysis indicate that the chaperones are bound to the assembled oligomers. The finding that a small fraction of chaperones is bound to the oligomers, prompted by SDS-PAGE and intrinsic fluorescence measurements, suggests that chaperones act as nucleation sites for the assembly of oligomers into larger species and explains why they are effective in reducing markedly oligomer toxicity even at highly sub-stoichiometric concentrations.
The molecular structure of the oligomers is preserved after chaperone interaction.
As a next step we set out to assess if chaperones promote a structural reorganisation of the oligomers, in addition to inducing their assembly. We took advantage of the ability to discriminate between the toxic HypF-N oligomers used in this work (type A) and nontoxic ones (type B) through the measurement of the fluorescence properties of oligomers labelled with PM at different positions in the sequence (14) . This probe monitors the presence of a short distance (≤10Å) between labelled positions in the oligomers, which becomes evident as an excimer band at 440 nm (14) . In particular, (Fig. 5B) , indicating that the spatial distribution of residues in the oligomers is preserved following interaction with the chaperones.
Furthermore, examination with Fourier transform infra-red (FTIR) spectroscopy indicated that no changes in secondary structure appeared to have occurred following the incubation of the oligomers with either αBcr or α 2 M (Fig. 5C ).
Discussion
Our data show that chaperones inhibit the cellular toxicity of extracellular protein oligomers under the conditions studied here. This behaviour appears to result from the ability of the chaperones to bind to oligomers and promote their further assembly into larger species, in the absence of any significant reorganisation of their internal molecular structure. This mechanism is extremely effective as it allows the chaperones to reduce oligomer toxicity at highly sub-stoichiometric levels.
Such an ability of molecular chaperones adds to their well established functions in facilitating protein folding, inhibiting protein aggregation and promoting the disaggregation and clearance of protein aggregates (6, 7, 10, 11) . In all our experiments the oligomers are formed before adding the chaperones, showing that the protective action of the latter also includes neutralisation of toxic oligomers after they have formed. This protective mechanism is not entirely novel, but evidence has been very sparse in the past, with reports often being contradictory and with undefined mechanisms (9, (18) (19) (20) (21) (22) .
These data also suggest that the size of extracellular protein aggregates is an inverse correlate of their toxicity. The chaperone-induced oligomer clusters are characterised by a reduction in their exposed hydrophobic surface and diffusional mobility, both of which are expected to reduce their toxicity to cells. It is therefore clear that chaperones can be valuable tools for understanding the factors governing oligomer toxicity.
Importantly, the results shown here suggest that the structure, function and mechanism of action of molecular chaperones may serve to guide the design of therapeutic interventions against diseases originating from extracellular protein aggregation. Indeed, the finding that natural molecular chaperones can inhibit the toxicity of aberrant protein aggregates after they are formed, with broad specificity and at very low concentrations, suggests that therapeutics based on the same type of intervention could be effective against such diseases.
Proteins
HypF-N was purified as previously described (14) . Aβ 42 and IAPP were purchased from SigmaAldrich (St. Louis, MO). Human Hsp70 and αBcr were purified as previously described (23, 24) .
Human Clu, α 2 M and Hp were purified as previously reported (25) (26) (27) . BSA and HEWL were obtained from Sigma-Aldrich.
Formation of protein oligomers
HypF-N was converted into toxic (type A) or nontoxic (type B) aggregates as previously reported (14) . Oligomers were centrifuged at 16100g for 10 min, dried under N 2 and resuspended in the cell culture medium without cells (for cell biology tests) or in 20 mM phosphate buffer, pH 7.0 (for biophysical/biochemical analysis). No significant dissolution of the oligomers or change in morphology/structure could be detected after this procedure, as previously reported (14) . Toxicity was measured in all cases under physiological conditions (pH 7.4, 37 °C, no organic solvents). Aβ 42 and IAPP oligomers were prepared as previously described (12, 13) and resuspended in the cell culture medium to 12 µM. Native proteins were diluted to 12 µM into the same medium. All oligomers were then incubated in the appropriate media for 1 h at 37 °C while shaking, without or with chaperones, and then added to cultured cells or subjected to biophysical/biochemical analysis. Oligomers of HypF-N, Aβ 42 and IAPP (at a corresponding monomer concentration of 12 µM) were incubated for 1 h without or with αBcr, Hsp70, Clu, Hp, α 2 M, HEWL or BSA (HypF-N:chaperone molar ratios as described above, HypF-N:HEWL and HypF-N:BSA molar ratios were 5:1), and then added to SH-SY5Y cells. The MTT reduction assay was performed as previously described (14) .
Further details are give in Supplementary Methods.
Measurement of intracellular Ca
2+
HypF-N oligomers (at a corresponding monomer concentration of 12 µM) were incubated for 1 h in the cell culture medium without or with αBcr, Hsp70, Clu, Hp or α 2 M and then added to SH-SY5Y cells seeded on glass coverslips for 60 min at 37 °C. Cells were then loaded with 10 µM fluo3-AM (Molecular Probes, Eugene, OR), as previously described (14, 15) . Cells were also treated with nontoxic HypF-N oligomers or the native protein (12 µM monomer). Cell fluorescence was analysed by confocal scanning microscopy, as previously described (14, 15) .
AFM
Samples prepared as detailed above were diluted from 5 to 100 times, as required, and 10 μl aliquots were deposited on freshly cleaved mica and dried under mild vacuum. Tapping mode AFM images were acquired in air using a Multimode SPM, equipped with a "E" scanning head (maximum scan size 10μm) and driven by a Nanoscope IV controller, and a Dimension 3100 SPM, equipped with a 'G' scanning head (maximum scan size 100μm) and driven by a Nanoscope IIIa controller (Digital Instruments, Bruker AXS GmbH, Karlsruhe, Germany). Single beam uncoated silicon cantilevers (type OMCL-AC160TS, Olympus, Tokyo, Japan) were used. The drive frequency was 290-310 kHz, the scan rate was 0.4-0. Confocal microscope images were acquired as previously described (14) .
SDS-PAGE
HypF-N oligomers, αBcr and α 2 M were incubated for 1 h in 20 mM phosphate buffer at pH 7.0 in isolation and in combination (48 µM HypF-N). Samples were then centrifuged for 10 min at 16100g. Aliquots of the P and SN fractions were subjected to SDS-PAGE using 15% polyacrylamide gels.
Intrinsic fluorescence
Intrinsic fluorescence spectra of the SN fractions collected for SDS-PAGE were acquired at 37 °C using a Perkin-Elmer LS 55 spectrofluorimeter (Wellesley, Massachusetts) and a 2X10mm quartz cell, an excitation wavelength of 280 nm. The spectrum of HypF-N oligomers was subtracted from that of the chaperone in the presence of HypF-N oligomers and all the spectra were normalized to the maximum fluorescence intensity of the chaperone spectrum.
Pyrene fluorescence
HypF-N variants carrying a single cysteine residue were labelled with PM as previously described (14), converted into toxic and nontoxic oligomers in homogeneous or 1:1 mixtures and then diluted 4-fold into 20 mM phosphate buffer at pH 7.0. Fluorescence emission spectra of these samples were acquired after 1 h without or with chaperones and analyzed as previously described (14) . HypF-N concentration was 12 µM.
FTIR spectroscopy
HypF-N oligomers were incubated with or without αBcr or α 2 M (48 µM HypF-N) and then centrifuged and resuspended in D 2 O twice to achieve a final protein concentration of ~15 mg ml -1 .
The sample was deposited on a KBr window in a semipermanent liquid cell and the FTIR spectra were recorded at room temperature using an FT/IR 4200 spectrophotometer (Jasco, Tokyo, Japan).
The system was constantly purged with N 2 . The resulting spectra were baseline corrected and smoothed.
Statistical analysis
All data were expressed as means ± standard deviation (SD). Comparisons were performed using ANOVA followed by Bonferroni's post-comparison test. The SD are reported in brackets. (C) FTIR amide I spectra of HypF-N oligomers after incubation without (black) and with αBcr (red) or α 2 M (purple).
